Precision Medicine in Thoracic Surgery: Chest Wall, Pleural, and Mediastinal Malignancies

Area of Science:

• Oncology
• Genomics
• Thoracic Surgery

Background:

• Precision medicine has revolutionized common cancer care.
• Rare thoracic malignancies, including mesothelioma and thymic tumors, have lagged in progress due to rarity and heterogeneity.
• Unique tumor biology presents opportunities for targeted therapies.

Purpose of the Study:

• To review the current precision medicine landscape for rare thoracic tumors.
• To highlight strategies and future directions for neoadjuvant and adjuvant therapies.
• To discuss the potential of targeted treatments to improve outcomes in these cancers.

Main Methods:

• Literature review of precision medicine applications in rare thoracic malignancies.
• Analysis of current targeted therapy strategies.
• Examination of neoadjuvant and adjuvant treatment settings.

Main Results:

• Advances in precision medicine offer new therapeutic avenues for rare thoracic tumors.
• Targeted therapies show potential to enhance surgical outcomes and patient survival.
• Heterogeneity of these rare cancers necessitates tailored treatment approaches.

Conclusions:

• Precision medicine holds significant promise for improving the management of rare thoracic cancers.
• Further research into unique molecular alterations is crucial for developing effective targeted therapies.
• Integrating precision medicine into neoadjuvant and adjuvant settings may optimize treatment efficacy.